From: Increased AURKA promotes cell proliferation and predicts poor prognosis in bladder cancer
Characteristic | n | AURKA expression (%) | Pearson χ2 | P | |
---|---|---|---|---|---|
High | Low or no | ||||
Total | 93 | 70 (75.27) | 23 (24.73) | Â | Â |
Age | Â | Â | Â | 2.596 | 0.122 |
 ≥ 65 | 65 | 52 (80.00) | 13 (20.00) |  |  |
 < 65 | 28 | 18 (64.29) | 10 (35.71) |  |  |
Gender | Â | Â | Â | 0.010 | 1.000 |
 Female | 25 | 19 (76.00) | 6 (24.00) |  |  |
 Male | 68 | 51 (75.00) | 17 (25.00) |  |  |
RC stage | Â | Â | Â | 18.766 | 0.001** |
 pTa | 5 | 0 (0.00) | 5 (100.00) |  |  |
 pT1 | 10 | 6 (60.00) | 4 (40.00) |  |  |
 pT2 | 17 | 13 (76.47) | 4 (23.53) |  |  |
 pT3 | 42 | 35 (83.33) | 7 (16.67) |  |  |
 pT4 | 19 | 16 (84.21) | 3 (15.79) |  |  |
RC grade | Â | Â | Â | 11.833 | 0.003** |
 high | 87 | 69 (78.16) | 18 (21.84) |  |  |
 low | 6 | 1 (16.67) | 5 (83.33) |  |  |
Histology | Â | Â | Â | 2.487 | 0.288 |
 TCC | 86 | 63 (73.25) | 23 (26.75) |  |  |
 TCC/CIS | 2 | 2 (100.00) | 0 (0.00) |  |  |
 TCC/square | 5 | 5 (100.00) | 0 (0.00) |  |  |
Lymph node status | Â | Â | Â | 5.876 | 0.053 |
 PN0 | 49 | 32 (65.31) | 17 (34.69) |  |  |
 PN+ | 28 | 25 (89.28) | 3 (10.72) |  |  |
 PNx | 16 | 13 (81.25) | 3 (18.75) |  |  |
Recurrence | Â | Â | Â | 0.304 | 0.635 |
 No | 52 | 38 (73.08) | 14(26.92) |  |  |
 Yes | 41 | 32 (78.05) | 9 (21.95) |  |  |
Last known status | Â | Â | Â | 2.651 | 0.266 |
 NED | 28 | 18 (64.28) | 10 (35.72) |  |  |
 DOC | 27 | 22 (81.48) | 5 (18.52) |  |  |
 DOD | 38 | 30 (78.95) | 8 (21.05) |  |  |
Metastasis | Â | Â | Â | 0.199 | 0.806 |
 No | 57 | 42 (73.68) | 15 (26.32) |  |  |
 Yes | 36 | 28 (77.78) | 8 (22.22) |  |  |